Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-43.60%
↑ 42% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-75.38%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -43.60% |
| 2023 | -182.53% |
| 2022 | 0.00% |